Evaluation of Effectiveness and Safety of Paliperidone Extended Release in Patients With Schizoaffective Disorder.
Status:
Completed
Trial end date:
2008-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to measure the effectiveness and assess the safety of two
dosages of the antipsychotic paliperidone extended-release (ER) in patients who are
experiencing an acute episode of schizoaffective disorder.
Phase:
Phase 3
Details
Lead Sponsor:
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.